Abbott baby formula plant on track to reopen within 1-2 weeks -FDA commissioner
2022.05.19 18:11
FILE PHOTO: Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid
WASHINGTON (Reuters) – Abbott Laboratories (NYSE:ABT) and the U.S. Food and Drug Administration are on track to reopen the company’s Sturgis, Michigan, baby formula manufacturing plant within one or two weeks, FDA Commissioner Robert Califf said on Thursday.
“I think we are on track to get it open within the next week to two weeks, most likely at the outer bound two weeks,” Califf told lawmakers at a U.S. House of Representatives Appropriations Subcommittee hearing.
The FDA cannot conclude whether cases of ill babies are directly related to the Abbott plant until its investigation is concluded, Califf said.
